Cardiac and Vascular Alterations in Resistant Hypertension

[1]  Philippe Van De Borne,et al.  Guidelines for the management of arterial hypertension , 2014 .

[2]  Michael Böhm,et al.  2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). , 2007, Journal of hypertension.

[3]  D. Bluemke,et al.  LV mass assessed by echocardiography and CMR, cardiovascular outcomes, and medical practice. , 2012, JACC. Cardiovascular imaging.

[4]  R. Schmieder,et al.  Salt intake determines retinal arteriolar structure in treatment resistant hypertension independent of blood pressure. , 2012, Atherosclerosis.

[5]  Heather M. Tavel,et al.  Incidence and Prognosis of Resistant Hypertension in Hypertensive Patients , 2012, Circulation.

[6]  M. Böhm,et al.  Renal sympathetic denervation reduces left ventricular hypertrophy and improves cardiac function in patients with resistant hypertension. , 2012, Journal of the American College of Cardiology.

[7]  L. C. Martins,et al.  Vascular stiffness and endothelial dysfunction: Correlations at different levels of blood pressure , 2012, Blood pressure.

[8]  Cerebral Microangiopathy in Treatment‐Resistant Hypertension , 2011, Journal of clinical hypertension.

[9]  M. Salvetti,et al.  RESISTANT HYPERTENSION IN A GENERAL POPULATION IN NORTHERN ITALY: PREVALENCE, ASSOCIATED CARDIOVASCULAR RISK FACTORS AND TARGET ORGAN DAMAGE: PP.42.362 , 2011 .

[10]  C. Cuspidi,et al.  Resistant hypertension and left ventricular hypertrophy: an overview. , 2010, Journal of the American Society of Hypertension : JASH.

[11]  M. Muiesan,et al.  Pulse wave velocity and cardiovascular risk stratification in a general population: the Vobarno study , 2010, Journal of hypertension.

[12]  E. Muxfeldt,et al.  Prognostic significance of baseline and serial changes in electrocardiographic strain pattern in resistant hypertension , 2010, Journal of hypertension.

[13]  E. Muxfeldt,et al.  Prognostic impact of baseline and serial changes in electrocardiographic left ventricular hypertrophy in resistant hypertension. , 2010, American heart journal.

[14]  S. Oparil,et al.  Rapid Reversal of Left Ventricular Hypertrophy and Intracardiac Volume Overload in Patients With Resistant Hypertension and Hyperaldosteronism: A Prospective Clinical Study , 2010, Hypertension.

[15]  E. Muxfeldt,et al.  A blunted decrease in nocturnal blood pressure is independently associated with increased aortic stiffness in patients with resistant hypertension , 2009, Hypertension Research.

[16]  E. Muxfeldt,et al.  Prognostic value of ventricular repolarization prolongation in resistant hypertension: a prospective cohort study , 2009, Journal of hypertension.

[17]  D. Goff,et al.  Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research. , 2008, Circulation.

[18]  E. Porteri,et al.  Vascular Remodeling and Duration of Hypertension Predict Outcome of Adrenalectomy in Primary Aldosteronism Patients , 2008, Hypertension.

[19]  A. Dominiczak,et al.  2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) , 2007, European heart journal.

[20]  T. Pickering.  Arterial Stiffness as a Cause of Resistant Hypertension? , 2007, Journal of clinical hypertension.

[21]  E. Muxfeldt,et al.  Importance of the Electrocardiographic Strain Pattern in Patients With Resistant Hypertension , 2006, Hypertension.

[22]  V. Papademetriou,et al.  Resistant Hypertension: Diagnosis and Management , 2006, Journal of cardiovascular pharmacology and therapeutics.

[23]  C. de Ciuceis,et al.  Changes in extracellular matrix in subcutaneous small resistance arteries of patients with primary aldosteronism. , 2006, The Journal of clinical endocrinology and metabolism.

[24]  E. Muxfeldt,et al.  True resistant hypertension: is it possible to be recognized in the office? , 2005, American journal of hypertension.

[25]  F. Cuccurullo,et al.  Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. , 2005, American journal of hypertension.

[26]  E. Muxfeldt,et al.  Combined QT Interval and Voltage Criteria Improve Left Ventricular Hypertrophy Detection in Resistant Hypertension , 2005, Hypertension.

[27]  U. Faire,et al.  Regression of left ventricular hypertrophy on long-term treatment with captopril of severe hypertensives refractory to standard triple treatment , 2004, European Journal of Clinical Pharmacology.

[28]  C. de Ciuceis,et al.  Prognostic Significance of Small-Artery Structure in Hypertension , 2003, Circulation.

[29]  C. Ram.  Management of refractory hypertension. , 2003, American journal of therapeutics.

[30]  W. Hall.  Resistant hypertension, secondary hypertension, and hypertensive crises. , 2002, Cardiology clinics.

[31]  F. Magrini,et al.  High prevalence of cardiac and extracardiac target organ damage in refractory hypertension , 2001, Journal of hypertension.

[32]  J. Spence.  Management of Resistant Hypertension in Patients with Carotid Stenosis: High Prevalence of Renovascular Hypertension , 2000, Cerebrovascular Diseases.

[33]  R. Zulli,et al.  Structural association between the carotid artery and the left ventricle in a general population in Northern Italy: the Vobarno study , 1998, Journal of hypertension.

[34]  L. Ruilope,et al.  Prognostic value of ambulatory blood pressure monitoring in refractory hypertension: a prospective study. , 1998, Hypertension.

[35]  M. Martín-Baranera,et al.  Target-organ damage and cardiovascular risk profile in resistant hypertension. Influence of the white-coat effect. , 1998, Blood pressure monitoring.

[36]  E. Schiffrin,et al.  Enhanced expression of endothelin‐1 gene in resistance arteries in severe human essential hypertension , 1997, Journal of hypertension.

[37]  E. Porteri,et al.  Vascular hypertrophy and remodeling in secondary hypertension. , 1996, Hypertension.

[38]  F. McAlister,et al.  Resistant hypertension: an overview. , 1996, The Canadian journal of cardiology.

[39]  D. Rizzoni,et al.  Association of change in left ventricular mass with prognosis during long-term antihypertensive treatment , 1995, Journal of hypertension.

[40]  J. Ménard,et al.  Effects of captopril and minoxidil on left ventricular hypertrophy in resistant hypertensive patients: a 6 month double-blind comparison. , 1990, Journal of the American College of Cardiology.